CDKN2B-AS1 and retinal disorder: It was revealed that the expression and activation levels of P65 in the retinal tissues of DR rats declined prominently after Lnc-RNA ANRIL knockdown, suggesting that the inhibition of Lnc-RNA ANRIL can significantly ameliorate retinopathy in diabetic rats by inhibiting P65 in the NF-κB signaling pathway [63].